Shape discrimination and the judgement of perfect symmetry: dissociation of shape from size.

We measured the accuracy with which subjects judged that a square or circle was perfectly symmetrical i.e. that aspect ratio (a/b) was exactly unity (where a and b were, respectively, the vertical and horizontal dimensions). Errors were remarkably small, ranging from 0.7 to 0.4% for the judgement of squareness and from 1.4 to < 0.1% for the judgement of circularity. Precision in judging aspect ratio was measured by requiring subjects to judge whether the aspect ratio (a/b)TEST of a test rectangle was greater or less than the aspect ratio (a/b)REF of a reference rectangle. Similar measurements were made for elliptical targets. To ensure that subjects based judgements on aspect ratio rather than a, b or (a-b), the area of each successive presentation was varied randomly. The just-discriminable percentage change of aspect ratio was as low as 1.6% at (a/b)REF = 1.0 (i.e. for a square or circular reference), and rose progressively as (a/b)REF was made progressively larger or smaller than 1.0. Aspect ratio discrimination threshold was independent of mean area over a sixteen-fold range of 0.25-4.0 deg2. For both rectangles and ellipses, the best value of aspect ratio discrimination threshold corresponded to a precision of encoding a and b of 14 sec arc or better. In further experiments, the method of constant stimuli was used to measure an aspect ratio aftereffect produced by adapting separately to rectangles of (a/b)ADAPT equal to 1.5, 1.0 and (1/1.5). Similar aftereffects were obtained whether the area of the test stimulus was fixed or varied randomly from trial to trial, and whether the test stimulus was rectangular or elliptical. The aftereffect could not be explained in terms of fatigue of neurons sensitive to linear dimension a or b. Nor could the aftereffect be explained in terms of the "contour repulsion" hypothesis, or in terms of orientation discrimination. We conclude (1) that the same neural mechanism determines aspect ratio discrimination threshold for rectangles and ellipses and (2) that this mechanism is sensitive to aspect ratio independently of linear dimensions. We propose that aspect ratio perception is determined by the balance of excitation of two pools of neurons that are selectively sensitive to different, but overlapping ranges of (a/b). One pool prefers aspect ratios > 1.0 and the others prefer aspect ratios < 1.0. We suppose that the two pools respond identically to changes in area (a * b).(ABSTRACT TRUNCATED AT 400 WORDS)     

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

PURPOSE: Renal cancer response to interleukin 2 (IL-2) therapy and patient survival has been correlated with tumor histology and carbonic anhydrase IX (CAIX) expression. In an effort to confirm and expand these observations, we examined CAIX expression in pathology specimens from renal cancer patients who had previously received IL-2 therapy. EXPERIMENTAL DESIGN: Paraffin-embedded tissue sections of renal cancer were immunostained with the MN-75 monoclonal antibody to CAIX and expression levels were correlated with histologic findings and clinical outcome. RESULTS: Tissue specimens were obtained from 66 patients; 27 of whom (41%) had responded to IL-2-based therapy. Fifty-eight specimens were assessed as clear cell, with 56, 33, and 4 having alveolar, granular, and papillary features, respectively. Twenty-four (36%), 31 (47%), and 11 (17%) were classified into good, intermediate, and poor prognosis groups according to the Upton pathology model. Forty-one specimens (62%) had high CAIX expression. Twenty-one of 27 (78%) responding patients had high CAIX expressing tumors compared with 20 of 39 (51%) nonresponders (odds ratio, 3.3; P = 0.04). Median survival was prolonged (P = 0.04) and survival >5 years was only seen in high CAIX expressers. In patients with intermediate pathologic prognosis, all nine responders had high CAIX expression versus 11 of 22 nonresponders. A resultant group with good pathologic prognosis alone or with intermediate pathologic prognosis and high CAIX contained 26 of 27 (96%) responders compared with 18 of 39 (46%) nonresponders (odds ratio, 30; P < 0.01) and exhibited longer median survival (P < 0.01). CONCLUSIONS: CAIX expression seems to be an important predictor of outcome in renal cell carcinoma patients receiving IL-2-based therapy and may enhance prognostic information obtained from pathology specimens.